Wordt geladen...
Recent advances in precision medicine for pancreatic ductal adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is one of the leading causes of cancer mortality worldwide. Although advances in systemic chemotherapy for PDAC have improved survival outcomes for patients with the disease, chemoresistance is a major treatment issue for unselected PDAC patient populations. T...
Bewaard in:
| Gepubliceerd in: | Ann Gastroenterol Surg |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8316748/ https://ncbi.nlm.nih.gov/pubmed/34337294 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ags3.12436 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|